Gil M. Labrucherie, SVP, COO & CFO at NEKTAR THERAPEUTICS (NKTR), sold 11,876 shares at $22.35 ($265K) on 2020-02-18, disclosed to the SEC on 2020-02-20.
Seasonal sale ($265k) by SVP, COO & CFO — this insider has traded NKTR in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.35 | 5,938 | $133K | 50.0% |
| 2 | $22.35 | 5,938 | $133K | 50.0% |
| Total | $22.35 avg | 11,876 | $265K | 100% |
| Filing → |
| NKTR | SELL | 2022-05-17 | $138K | — | Filing → |
| RZLT | BUY | 2022-05-09 | $400K | — | Filing → |
| NKTR | SELL | 2022-02-18 | $166K | — | Filing → |